Protagonist Therapeutics Inc buy Barclays PLC
Start price
26.02.26
/
50%
€77.00
Target price
26.02.27
€95.61
Performance (%)
54.55%
Price
21:29
€119.00
Summary
This prediction is currently active. The BUY prediction by Barclays_PLC for Protagonist Therapeutics Inc has seen massive gains of 54.55%. This prediction currently runs until 26.02.27. The prediction end date can be changed by Barclays_PLC at any time. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Protagonist Therapeutics Inc | -4.167% | -4.167% |
| iShares Core DAX® | 2.334% | 1.011% |
| iShares Nasdaq 100 | 1.370% | -3.612% |
| iShares Nikkei 225® | 2.437% | -7.461% |
| iShares S&P 500 | 1.259% | 0.677% |
Comments by Barclays_PLC for this prediction
In the thread Protagonist Therapeutics Inc diskutieren
Protagonist Therapeutics (PTGX) had its price target raised by Barclays PLC from $108.00 to $113.00. They now have an "overweight" rating on the stock.
Ratings data for PTGX provided by MarketBeat
Stopped prediction by Barclays_PLC for Protagonist Therapeutics Inc
Protagonist Therapeutics Inc
Start price
Target price
Perf. (%)
€88.00
19.03.26
19.03.26
€103.58
19.03.27
19.03.27
35.23%
21:29
21:29
Protagonist Therapeutics Inc
Start price
Target price
Perf. (%)
€69.00
07.11.25
07.11.25
€76.27
07.11.26
07.11.26
72.46%
21:29
21:29
Protagonist Therapeutics Inc
Start price
Target price
Perf. (%)
€53.00
17.09.25
17.09.25
€60.73
17.09.26
17.09.26
124.53%
21:29
21:29